Octreotide as an antineoplastic agent in the treatment of functional and nonfunctional neuroendocrine tumors Academic Article Article uri icon

Overview

MeSH Major

  • Mycosis Fungoides
  • Sezary Syndrome

abstract

  • Octreotide may influence the natural history of neuroendocrine tumors. The survival in patients treated with octreotide, as measured from the time of progression of disease, compares favorably with that of historical controls. Proof of a survival advantage for patients treated with octreotide would require a multicenter, randomized trial.

publication date

  • January 1993

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1002/1097-0142(19930701)72:1<244::AID-CNCR2820720143>3.0.CO;2-Q

PubMed ID

  • 8389666

Additional Document Info

start page

  • 244

end page

  • 8

volume

  • 72

number

  • 1